PT350 Jim Gilligan Psilocybin and Accessing the Off Switch For Nociplastic Pain
In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain.\xa0
www.psychedelicstoday.com